Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash Flows from Operating Activities:
Net Loss	$ (1,902,429)	$ (800,818)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization	9,656	15,031
Stock-based compensation	114,500	0
Changes in assets and liabilities:
Prepaid expenses and other receivables	9,258	(17,347)
Accounts payable	5,355	72,401
Liability due to related party	84,896	(221,735)
Other liabilities and accrued expenses	136,117	39,147
Accrued interest receivable	980	(54,295)
Net cash used in operating activities	(1,541,667)	(967,616)
Cash Flows from Investing Activities:
Capitalized patent costs	(7,066)	(25,245)
Fixed rate savings account	1,324,000	639,460
Net cash provided by investing activities	1,316,934	614,215
Cash Flows from Financing Activities
Proceeds from exercise of common stock options	500	0
Net cash provided by financing activities	500	0
Net decrease in cash	(224,233)	(353,401)
Effect of exchange rate changes on cash	(71,954)	39,581
Cash at beginning of period	822,335	911,359
Cash at end of period	526,148	597,539
Supplemental disclosure of non-cash financing activities:
Conversion of Series A preferred stock to common stock	137,324	0
Deferred offering costs included in accrued expenses	$ 108,450	$ 0